Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

TRPC5 Inhibitors

TRPC5 inhibitors encompass a diverse group of compounds meticulously designed to modulate the activity of Transient Receptor Potential Canonical 5 (TRPC5) channels, which play a significant role in calcium signaling and ion homeostasis within cells. These inhibitors are developed through a combination of structural insights and mechanistic studies, often employing advanced techniques such as computational modeling, high-throughput screening, and chemical synthesis. The primary objective is to engineer compounds with precise capabilities to selectively interact with TRPC5 channels, potentially influencing their role in cellular responses and calcium regulation. By targeting TRPC5, these inhibitors offer crucial tools for investigating the complex processes underlying calcium-mediated signaling, shedding light on the intricate mechanisms that contribute to cellular functions. The exploration of TRPC5 inhibitors contributes to a deeper understanding of the finely tuned interactions within ion channels, revealing insights into the nuanced dynamics that govern calcium influx and cellular responses.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

4-Methyl-2-(1-piperidinyl)-quinoline

5465-86-1sc-483337
25 mg
$430.00
(0)

An experimental inhibitor, ML204 has been explored for its interactions with TRPC5 channels and its potential role in modulating ion flux.

CRAC Channel Inhibitor, BTP2

223499-30-7sc-221441
5 mg
$189.00
9
(1)

A selective blocker, YM-58483 has been investigated for its effects on TRPC5-mediated ion currents and its potential impact on cellular responses.

SAR7334

1333210-07-3sc-507445
10 mg
$510.00
(0)

This compound has been investigated for its potential inhibitory effects on TRPC5-mediated calcium signaling and its role in cellular responses.